Market Research Logo

Drug Addiction - Pipeline Review, H2 2015

Drug Addiction - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H2 2015’, provides an overview of the Drug Addiction’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Drug Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Drug Addiction and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Drug Addiction
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Drug Addiction and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Drug Addiction products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Drug Addiction pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Drug Addiction
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Drug Addiction pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Drug Addiction Overview
Therapeutics Development
Pipeline Products for Drug Addiction - Overview
Pipeline Products for Drug Addiction - Comparative Analysis
Drug Addiction - Therapeutics under Development by Companies
Drug Addiction - Therapeutics under Investigation by Universities/Institutes
Drug Addiction - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Drug Addiction - Products under Development by Companies
Drug Addiction - Products under Investigation by Universities/Institutes
Drug Addiction - Companies Involved in Therapeutics Development
Addex Therapeutics Ltd
Aphios Corporation
Astellas Pharma Inc.
Curemark, LLC
Embera NeuroTherapeutics, Inc.
Immunovaccine, Inc.
Kyorin Pharmaceutical Co., Ltd.
Lightlake Therapeutics Inc.
Omeros Corporation
Rottapharm SpA
Saniona AB
Teva Pharmaceutical Industries Limited
Drug Addiction - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(oxazepam + metyrapone) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
18-MC - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ADX-71441 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ADX-88178 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ASP-2905 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
cannabidiol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CM-1212 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CR-5542 Series - Drug Profile
Product Description
Mechanism of Action
R&D Progress
dronabinol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug for Dependence - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EROA-101 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ibudilast - Drug Profile
Product Description
Mechanism of Action
R&D Progress
JQ-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LT-22 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MC-100093 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
N-S2359 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
OMS-527 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Drug Addiction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Activate Kappa Opioid Receptor for CNS - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Activate Delta Opioid Receptor for Immunology, CNS and Metabolic Disorders - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Block VMAT2 for Methamphetamine Addiction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit CB1 Receptor for Cannabinoid Abuse and Drug Addiction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit DAT and SERT for CNS Disorders - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Kappa Opioid Receptor for CNS - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Target 5HT2 for CNS and Metabolic Disorders - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Target Kappa Opioid Receptors for Drug Addiction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TV-1380 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine for Cocaine Addiction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine for Cocaine Addiction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine for Methamphetamine Addiction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug Addiction - Recent Pipeline Updates
Drug Addiction - Dormant Projects
Drug Addiction - Discontinued Products
Drug Addiction - Product Development Milestones
Featured News & Press Releases
Aug 13, 2015: Saniona Announces That FDA Has Approved The IND For NS2359 In Cocaine Addiction
Jun 16, 2015: MediciNova Announces New Article Published on MN-166 in Addiction Biology
May 28, 2015: Embera NeuroTherapeutics Initiates Phase 1 Clinical Trial to Test EMB-001 as a Novel Treatment for Addictions
Apr 10, 2015: HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction
Sep 23, 2014: Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy
Aug 09, 2013: Curemark wins patent for CM-1212 to treat drug, alcohol addiction
Jun 18, 2013: MediciNova Announces Presentation Of Preliminary Results From Phase Ib Study Of MN-166 In Methamphetamine Addiction At 75th Annual Meeting Of CPDD
Feb 25, 2013: MediciNova's MN-166 Receives Fast Track Designation From FDA For Treatment Of Methamphetamine Dependence
Jan 18, 2013: Research team including Dr Gianluca Baio funded by the MRC
Jan 03, 2013: MediciNova Provides Development Update On MN-166
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Drug Addiction, H2 2015
Number of Products under Development for Drug Addiction - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Drug Addiction - Pipeline by Addex Therapeutics Ltd, H2 2015
Drug Addiction - Pipeline by Aphios Corporation, H2 2015
Drug Addiction - Pipeline by Astellas Pharma Inc., H2 2015
Drug Addiction - Pipeline by Curemark, LLC, H2 2015
Drug Addiction - Pipeline by Embera NeuroTherapeutics, Inc., H2 2015
Drug Addiction - Pipeline by Immunovaccine, Inc., H2 2015
Drug Addiction - Pipeline by Kyorin Pharmaceutical Co., Ltd., H2 2015
Drug Addiction - Pipeline by Lightlake Therapeutics Inc., H2 2015
Drug Addiction - Pipeline by Omeros Corporation, H2 2015
Drug Addiction - Pipeline by Rottapharm SpA, H2 2015
Drug Addiction - Pipeline by Saniona AB, H2 2015
Drug Addiction - Pipeline by Teva Pharmaceutical Industries Limited, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Drug Addiction Therapeutics - Recent Pipeline Updates, H2 2015
Drug Addiction - Dormant Projects, H2 2015
Drug Addiction - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Drug Addiction, H2 2015
Number of Products under Development for Drug Addiction - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report